Versar, Inc. (NYSE Amex:VSR) announced today that it was awarded a five-year, $7.6 million contract to review and evaluate pesticide product and residue chemistry data by the Office of Pesticide Programs (OPP), Health Effects Division (HED), of the U.S. Environmental Protection Agency (EPA). The EPA’s award of this new contract to Versar increases the total number of contracts to six currently managed by Versar’s Exposure and Risk Assessment Division. Under this new contract, Versar will review and evaluate product and residue chemistry data for the registration and re-registration of pesticides; perform data analysis and database development; and prepare technical presentations. The support under this contract will assist the OPP under their regulatory mandates, and will continue Versar’s more than 20 years of support to the EPA’s pesticide exposure assessment programs. Tony Otten, CEO of Versar, said, "Versar continues to expand our funded backlog with the win of important new contracts. While Versar has worked with the EPA’s pesticides program for two decades, this win moves us into new areas and scientific disciplines. The EPA’s pesticides programs are among the EPA’s highest priorities to better characterize chemical exposures and risks to our communities. Versar brings innovative approaches and rigorous scientific analysis to support EPA’s programs that ensure the safety of all our citizens." VERSAR, INC., headquartered in Springfield, VA, is a publicly held international professional services firm supporting government and industry in national defense/homeland defense programs, environmental health and safety and infrastructure revitalization. VERSAR operates a number of web sites, including the corporate Web sites, http://www.versar.com, http://www.homelanddefense.com, http://www.geomet.com; http://www.viap.com; http://www.dtaps.com; www.ppsgb.com; www.adventenv.com. This press release contains forward-looking information. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described herein and in Versar’s Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended June 26, 2009. The forward-looking statements are made as of the date hereof and Versar does not undertake to update its forward-looking statements.